Healthcare -
Biotechnology - NASDAQ - CH
$ 43.81
5.64 %
$ 2.76 B
Market Cap
-34.5
P/E
MLTX - STOCK-BASED COMPENSATION
Stock-based Compensation MLTX - MoonLake Immunotherapeutics
7.11 M
LAST VALUE
2457.63%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR